Discovery, Characterization, and Manufacture of Peptide Radiopharmaceuticals

A new wave of drugs that achieves targeted delivery of radioisotopes is rapidly gaining momentum. One area that is showing considerable promise is the incorporation of an isotope-chelating moiety into a peptide ligand for targeting cell surface receptors on cancer cells. In this webinar, we will discuss strategies for the discovery and optimization of new peptide ligands for such targets, as well as their synthesis, efficacy, metabolism/distribution, and manufacture.